SGT-501 is a novel gene therapy for rare, life-threatening, genetic arrhythmogenic disease with no approved therapies - - SGT-501 has received Orphan Drug Designation and Rare Pediatric Disease Design ...

Background Stereotactic arrhythmia radioablation (STAR) is a novel, non-invasive treatment for therapy-refractory ventricular ... died during follow-up (table 2). Heart failure was the most frequently ...

Atrial fibrillation (Afib) is one of the most common heart rhythm disorders, affecting millions worldwide. It occurs when the ...

Colombo celebrates Indonesia The Indonesian Embassy in Colombo hosted the Indonesian Bazaar and Cultural Show at their ...

When it comes to dream destination, you don’t have to look beyond Colombo’s skyscape. Blending colonial elegance seaside ...

Just a dozen patients have undergone the new treatment that uses electrical pulses to target problem areas inside the heart.

This pioneering heart rhythm management was applied to a 33-year-old male patient, Ravi (name changed), a car driver by profession from Tripura, Agartala.

For millions of people with heart failure, the latest treatment options — including advanced surgical procedures and innovative devices to assist a failing heart — can be game-changing ...

Nearly 14 million Americans live with arrhythmias. Learn to identify the warning signs of these common heart rhythm disorders and the breakthrough treatments offering 94% success rates.

Advances in heart failure treatment have reduced hospitalizations by up to 30% and extended lives by years. Learn about prevention strategies and research developments.

The Heart Rhythm Society's annual Heart Rhythm meeting convenes 9,500 of the world's finest clinicians, scientists, researchers, and innovators in cardiac pacing and electrophysiology.

Sinus bradycardia is defined as a resting heart rate of under 60 beats per minute that arises from the sinus node, which sets the heart rhythm. Sinus bradycardia can be normal for some people, but it ...